8-K - Pacira BioSciences, Inc. (0001396814) (Filer)
Published . Updated .
Key takeaways
- 8-K - Pacira BioSciences filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: PCRX
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Pacira BioSciences filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- PCRX Pacira BioSciences+42.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Pacira BioSciences belongs to, so it often moves with news about it.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and is a peer of Pacira BioSciences in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson is a peer of Pacira BioSciences in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.3% 30d
AbbVie is a peer of Pacira BioSciences in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+5.9% 19d
Merck is a peer of Pacira BioSciences in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+13.0% 30d
Abbott Laboratories is a peer of Pacira BioSciences in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| PCRX | -0.11% | -0.14% | base | after close | after close | after close | after close |
| XLV | -0.05% | -0.52% | base | after close | after close | after close | after close |
| LLY | +3.64% | +3.08% | base | after close | after close | after close | after close |
| JNJ | +0.29% | -2.31% | base | after close | after close | after close | after close |
| ABBV | +2.38% | -0.72% | base | after close | after close | after close | after close |
| MRK | +1.80% | -1.52% | base | after close | after close | after close | after close |
| ABT | -6.44% | -3.65% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001628280-26-071129 Size: 152 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 5 Nov 2026: Pacira BioSciences (PCRX) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -0.72% | final price |
| ABBV | five days earlier | +2.38% | final price |
| ABT | three days earlier | -3.65% | final price |
| ABT | five days earlier | -6.44% | final price |
| JNJ | three days earlier | -2.31% | final price |
| JNJ | five days earlier | +0.29% | final price |
| LLY | three days earlier | +3.08% | final price |
| LLY | five days earlier | +3.64% | final price |
| MRK | three days earlier | -1.52% | final price |
| MRK | five days earlier | +1.80% | final price |
| Pacira BioSciences (PCRX) | three days earlier | -0.14% | final price |
| Pacira BioSciences (PCRX) | five days earlier | -0.11% | final price |
| XLV | three days earlier | -0.52% | final price |
| XLV | five days earlier | -0.05% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 58 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 34 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 48 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Abbott Laboratories (ABT), worth $1,001 - $15,000 on 17 Sep 2026. That is 49 days before publication. Filed 30 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Pacira BioSciences, Inc. (0001396814) (Filer)”
Companies carried with this story
- PCRX Pacira BioSciences
Pacira BioSciences (PCRX) is linked, with no stored direction, high confidence in the 5 Nov 2026 story “8-K - Pacira BioSciences, Inc. (0001396814) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> PCRX
How “8-K - Pacira BioSciences, Inc. (0001396814) (Filer)” reaches Pacira BioSciences (PCRX)
On 5 Nov 2026, “8-K - Pacira BioSciences, Inc. (0001396814) (Filer)” is the story that connects Pacira BioSciences (PCRX) to this story.
Pacira BioSciences (PCRX) is on the page because SEC 8-K filing -> direct issuer disclosure -> PCRX
Dates and price levels for Pacira BioSciences (PCRX)
PCRX traded between 36.27 and 36.67 across 20 sessions. The latest close on file is 36.42.
How strong the case is around Pacira BioSciences (PCRX)
14 out of 100
“8-K - Pacira BioSciences, Inc. (0001396814) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.